Harmony Biosciences Holdings, Inc. (HRMY) Revenue History
Harmony Biosciences Holdings, Inc. (HRMY) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2020-12-31 | $159.74M |
| 2021-12-31 | $305.44M |
| 2022-12-31 | $437.86M |
| 2023-12-31 | $582.02M |
| 2024-12-31 | $714.73M |
| 2025-12-31 | $868.45M |
How HRMY compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc. | $874.84M |
| NEOG | Neogen Corporation | $870.40M |
| INNV | InnovAge Holding Corp. | $853.70M |
| VREX | Varex Imaging Corporation | $844.60M |
| MYGN | Myriad Genetics Inc. | $824.50M |
These are five companies in the same sector as HRMY with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Harmony Biosciences Holdings, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("HRMY", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | HRMY | $38.15 | +0.21% | 0.38M |
| 3 | ||||
| 4 | ||||
| 5 |